Graduate Periodontics Clinic, University of Louisville
Louisvile, Kentucky, 40202, United States
NCT Number: NCT01900964
A non-resorbable PTFE (teflon) membrane will be compared to a resorbable collagen membrane when used for a post-extraction ridge preservation procedure to prevent the bone loss that typically occurs. The hypothesis is that there will be no difference in the clinical and histologic results between the two membranes.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Louisvile, Kentucky, 40202, United States
Patient Selection 30 patients will be selected that meet the following criteria:
Inclusion criteria
Exclusion criteria
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-
Exclusion criteria
The non-resorbable PTFE barrier membrane will be surgically placed in conjunction with a ridge preservation procedure.
A resorbable collagen membrane is surgically placed in conjunction with a ridge preservation procedure.
Time frame: Time 4 months
The crestal ridge width will be measured with a digital caliper at the baseline exam and at the 4 month examination.
Time frame: Time 4 months
A trephine core will be taken at 4 months immediately prior to implant placement from the implant osteotomy site.
University of Louisville
Other
Ridge Preservation Comparing the Clinical and Histologic Healing of a PTFE Non-resorbable vs. a Collagen Membrane With an Intrasocket Mineralized Cancellous Allograft Plus a Facial Overlay Bovine Xenograft.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05867784
Clinical Efficacy, Crohn Disease
Wenzhou, Zhejiang, China
View Trial DetailsNCT02467946
Clinical Efficacy, Safety
Nice, France
View Trial DetailsNCT05144295
Chemically-Induced Disorders, Clinical Efficacy
Alexandria, Egypt
View Trial DetailsNCT01431131
Bone Diseases, Bone Resorption
Louisville, Kentucky, United States
View Trial Details